Showing results (11-20 of 103) with videos related to
Sort By:
Pageof 11
Expert Opinion on Pharmacotherapy|May 5, 2001
TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanerceptT R Mikuls, L W MorelandOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 27, 2019
Glucocorticoid-induced osteoporosis: 2019 concise clinical reviewG Adami, K G SaagClinical and Experimental Rheumatology|November 24, 2004
Glucocorticoid use in rheumatoid arthritis: benefits, mechanisms, and risksH B Townsend, K G SaagDrug Safety|January 8, 1999
Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?T M Karplus, K G SaagAnnals of the Rheumatic Diseases|April 29, 2006
Sex differences in gout epidemiology: evaluation and treatmentL R Harrold, R A Yood, T R Mikuls, et al.Clinical and Experimental Rheumatology|November 29, 2007
Challenges in defining and improving osteoporosis quality of careA Warriner, J R Curtis, K G SaagThe American Journal of Gastroenterology|October 1, 1989
Infectious diarrhea secondary to Enteromonas hominisJ R Spriegel, K G Saag, T K TsangClinical and Experimental Rheumatology|December 17, 2008
Mortality and osteoporotic fractures: is the link causal, and is it modifiable?G G Teng, J R Curtis, K G SaagThe Journal of Rheumatology|November 1, 1990
An eosinophilia-myalgia syndrome associated with an L-tryptophan containing productK G Saag, R Goldschmidt, H Vernof, et al.Rheumatology (Oxford, England)|March 17, 2005
The cost of glucocorticoid-associated adverse events in rheumatoid arthritisM Pisu, N James, S Sampsel, et al.Pageof 11